Related Experiment Video
Updated: Sep 25, 2026

Developing a Clinically Relevant Hemorrhagic Shock Model in Rats
Published on: March 22, 2024
Effect of a delta receptor agonist on duration of survival during hemorrhagic shock
Richard L Summers1, Zizhuang Li, Drew Hildebrandt
1Department of Emergency Medicine, University of Mississippi Medical Center, Jackson 39216, USA. rsummers@pol.net
Objectives:
Selective delta receptor agonists have been shown to stabilize membrane physiologic processes, reduce metabolic rates, and provide protection against ischemic insults through K(ATP) channel opening in a variety of organ beds. However, their potential for affecting outcomes in states of generalized ischemia has not been explored. The authors examined the effect of the nonselective delta receptor agonist, DADLE (D-Ala2-Leu5-enkephalin), on hemodynamic stability and duration of survival in an animal model of severe hemorrhagic shock.
Methods:
Conscious Sprague Dawley rats with indwelling catheters were hemorrhaged at a rate of 3.25 mL/100 grams over 20 minutes after half of the group received 1% DADLE (1 mg/kg IV). Following the hemorrhage, all rats were continuously monitored for heart rate (HR), mean arterial pressure (MAP), and life signs for up to three hours (death defined as apnea, systolic blood pressure < 30 mm Hg without pulsations, and electroencephalographic silence). Survival rates and hemodynamic trends were compared between the control and DADLE-treated groups.
Results:
In the 14 rats studied (8 DADLE; 6 controls), initial hemorrhage resulted in similar hemodynamic shock (average MAP fall: 118 to 59 vs 119 to 55 mm Hg). Analysis of survival at 3.5 hours revealed statistically significant differences between the control and DADLE groups. While 50% of the DADLE group survived past the three hours, no control animals were still alive at the end of the experimental period. The MAP trended downward and the HR increased for the control group, but all hemodynamic parameters stabilized in the rats treated with DADLE.
Conclusions:
Most current strategies for treating shock focus on the supply side of resuscitation. The coordinated various actions of DADLE have the potential to work in concert in the intact organism to improve overall survival during severe hemorrhagic shock. In an animal model of severe hemorrhagic shock, there was improvement in hemodynamic stability and a prolonged survival with DADLE treatment. Physiologic manipulation with DADLE appears to be a way to improve survival during shock with possible clinical implications.
Insights
DADLE (D-Ala2-Leu5-enkephalin), a delta receptor agonist, significantly improved survival and hemodynamic stability in rats experiencing severe hemorrhagic shock. This study suggests DADLE may offer a novel therapeutic approach for shock resuscitation.
Area of Science:
- Pharmacology
- Physiology
- Critical Care Medicine
Background:
- Selective delta receptor agonists stabilize physiological processes and protect against ischemia via K(ATP) channel opening.
- The impact of delta receptor agonists on generalized ischemia, such as hemorrhagic shock, remains unexplored.
Purpose of the Study:
- To investigate the effects of the nonselective delta receptor agonist DADLE (D-Ala2-Leu5-enkephalin) on hemodynamic stability and survival in a rat model of severe hemorrhagic shock.
Main Methods:
- Conscious Sprague Dawley rats received DADLE or a control treatment before undergoing induced hemorrhagic shock.
- Hemodynamic parameters (mean arterial pressure, heart rate) and survival were monitored for three hours post-hemorrhage.
Main Results:
- Hemorrhage induced similar initial hemodynamic shock in both groups.
- DADLE treatment resulted in statistically significant improved survival (50% at 3.5 hours) compared to controls (0%).
- Hemodynamic parameters stabilized in the DADLE group, while controls showed progressive deterioration.
Conclusions:
- DADLE administration improved hemodynamic stability and prolonged survival in a severe hemorrhagic shock model.
- Physiological manipulation with DADLE shows potential for improving shock resuscitation outcomes.
- DADLE's coordinated actions may offer a novel therapeutic strategy for clinical shock management.
Related Concept Videos
Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

